A mesothelioma clinical trial (also clinical research) is a research study in human volunteers to answer specific health questions. Carefully conducted clinical trials are the fastest and safest way to find treatments that work in people and ways to improve health. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.
The benefits of participating in a clinical trial include the following:
- Participants have access to promising new approaches that are often not available outside the clinical trial setting.
- The approach being studied may be more effective than the standard approach.
- Participants receive regular and careful medical attention from a research team that includes doctors and other health professionals.
- Participants may be the first to benefit from the new method under study.
- Results from the study may help others in the future.
The possible risks of participating in a clinical trial include the following:
- New drugs or procedures under study are not always better than the standard care to which they are being compared.
- New treatments may have side effects or risks that doctors do not expect or that are worse than standard care.
- Participants in randomized trials will not be able to choose the approach they receive.
- Health insurance and managed care providers may not cover all patient care costs in a study.
- Participants may be required to make more visits to the doctor than they would if they were not in the clinical trial.
Ideas for clinical trials usually come from researchers. After researchers test new therapies or procedures in the laboratory and in animal studies, the treatments with the most promising laboratory results are moved into clinical trials. During a mesothelioma clinical trial, more and more information is gained about a new treatment, its risks and how well it may or may not work.
Clinical trials are sponsored or funded by a variety of organizations or individuals such as physicians, medical institutions, foundations, voluntary groups, and pharmaceutical companies, in addition to federal agencies such as the National Institutes of Health (NIH), the Department of Defense (DOD), and the Department of Veteran's Affairs (VA). Trials can take place in a variety of locations, such as hospitals, universities, doctors' offices, or community clinics.
The clinical trial process depends on the kind of trial being conducted (See What are the different types of clinical trials?) The clinical trial team includes doctors and nurses as well as social workers and other health care professionals. They check the health of the participant at the beginning of the trial, give specific instructions for participating in the trial, monitor the participant carefully during the trial, and stay in touch after the trial is completed.
Some clinical trials involve more tests and doctor visits than the participant would normally have for an illness or condition. For all types of trials, the participant works with a research team. Mesothelioma clinical trial participation is most successful when the protocol is carefully followed and there is frequent contact with the research staff.
There are several types of clinical trials:
Prevention trials study ways to reduce the risk, or chance, of developing cancer. Most prevention trials are conducted with healthy people who have not had cancer. Some trials are conducted with people who have had cancer and want to prevent the return of cancer (recurrence), or reduce the chance of developing a new type of cancer.
Screening trials study ways to detect cancer. They are often conducted to determine whether finding cancer before it causes symptoms decreases the chance of dying from the disease. These trials involve people who do not have any symptoms of cancer.
Diagnostic trials study tests or procedures that could be used to identify cancer more accurately and at an earlier stage. Diagnostic trials usually include people who have signs or symptoms of cancer.
Treatment trials are conducted with people who have cancer. They are designed to answer specific questions about, and evaluate the effectiveness of, a new treatment or a new way of using a standard treatment. These trials test many types of treatments, such as new drugs, vaccines, new approaches to surgery or radiation therapy, or new combinations of treatments.
Supportive care (or quality of life) trials explore ways to improve the comfort and quality of life of cancer patients and cancer survivors. These trials may study ways to help people who are experiencing nausea, vomiting, sleep disorders, depression, or other effects from cancer or its treatment.
Genetics studies are sometimes part of another cancer clinical trial. The genetics component of the trial may focus on how genetic makeup can affect detection, diagnosis, or response to cancer treatment.
Population and family-based genetic research studies differ from traditional cancer clinical trials. In these studies, researchers look at tissue or blood samples, generally from families or large groups of people, to find genetic changes that are associated with cancer. People who participate in genetics studies may or may not have cancer, depending on the study. The goal of these studies is to help understand the role of genes in the development of cancer.
What are the phases of clinical trials?
Clinical trials are conducted in phases. The trials at each phase have a different purpose and help scientists answer different questions:
There are some phases of clinical trials in which a treatment is studied before the treatment is eligible for approval by the FDA (Food and Drug Administration).
phase I trial
The first step in testing a new treatment in humans. These studies test the best way to give a new treatment (for example, by mouth, intravenous infusion, or injection) and the best dose. The dose is usually increased a little at a time in order to find the highest dose that does not cause harmful side effects. Because little is known about the possible risks and benefits of the treatments being tested, phase I trials usually include only a small number of patients who have not been helped by other treatments. The purpose of a Phase I study is to find the best way to give a new treatment and how much of it can be given safely. Physicians watch patients carefully for any harmful side effects. The research treatment has been well tested in laboratory and animal studies, but the side effects in patients are not completely predictable.
phase I/II trial
phase II trial A study to test whether a new treatment has an anticancer effect (for example, whether it shrinks a tumor or improves blood test results) and whether it works against a certain type of cancer. Phase II trials determine the effectiveness of a research treatment after safety has been evaluated in a Phase I trial. Patients are closely observed for an anticancer effect by careful measurement of cancer sites present at the beginning of the trial. In addition to monitoring patients for response, any side effects are carefully recorded and assessed.
A trial to study the safety, dosage levels, and response to a new treatment.
phase II/III trial
A trial to study response to a new treatment and the effectiveness of the treatment compared with the standard treatment regimen.
phase III trial
A study to compare the results of people taking a new treatment with the results of people taking the standard treatment (for example, which group has better survival rates or fewer side effects). In most cases, studies move into phase III only after a treatment seems to work in phases I and II. Phase III trials may include hundreds of people. Phase III trials require entry of large numbers of patients; some trials enroll thousands of patients. One of the groups may receive standard (the most accepted) treatment, so the new treatments can be directly compared. The group that receives the standard treatment is called the "control group. " For example, one group of patients (the control group) may receive the standard chemotherapy for a certain type of cancer, while another patient group may receive another type of chemotherapy that may or may not contain an investigational drug to see if this improves survival. All patients in Phase III trials are monitored closely for side effects, and treatment is discontinued if the side effects are too severe.
phase IV trial
After a treatment has been approved and is being marketed, it is studied in a phase IV trial to evaluate side effects that were not apparent in the phase III trial. Thousands of people are involved in a phase IV trial.
Non-Drug Related Clinical Trials
Non-drug related clinical trials are much the same as drug clinical trials with the exception that they do not always require FDA approval. Whereas drug clinical trials consist of four phases, non-drug related clinical trials typically consist of three.
Although the FDA does not regulate the development of new treatment modalities, it does regulate any newly developed medical devices used in the practice of such treatments. For example, the development of a new surgical procedure aimed at curing malignant mesothelioma is not regulated by the FDA; however, a newly developed surgical tool used to perform the surgery does require FDA approval. The FDA approves the safety and efficacy of the device as opposed to the safety and efficacy of the treatment.
The Mesothelioma Applied Research Foundation (MARF) lists mesothelioma clinical trials on their site. Once you find a trial on one of these web sites that seems like it might be beneficial, you should call the center where it's being conducted to find out as much as you can about the risks, potential benefits, eligibility requirements, and costs and then discuss the suitability of the trial with your medical team and your family or close friends. If they have other questions you didn't think of, call back and ask the center conducting the test.
The same clinical trial may be conducted at various locations so be sure to ask for all locations. You may find a location close to home, or close to the homes of relatives or friends with whom you can stay during treatment. It is certainly convenient to find clinical trials close to home, but remember there are organizations that can help you with travel expenses and a place to stay.
The cost of clinical trials can be tricky and it's important to determine who pays for what.
There are two types of costs in clinical studies:
- patient care costs
- research costs
Patient care costs are generally those which you would have even if you were receiving traditional treatment, such as doctor visits, hospital stays, lab tests, x-rays, and the like. The patient is usually responsible for these costs and you need to determine whether your insurer will pay for them.
Often, the cost of investigational drugs and research costs, such as tests performed solely for research purposes, are covered by the sponsor of a clinical trial but you should always check which costs are covered by the sponsor and which are not.
Medicare reimburses certain patient care costs in clinical trials. See their website or call 1-800-MEDICARE (1-800-633-4227). In NCI-sponsored trials, TRICARE, the Department of Defense's healthcare program covers certain patient care costs and the VA covers certain costs for eligible veterans. See the cancer.gov website for more information.
Some states now require coverage of patient care costs (not research costs) in certain clinical trials. Click here to see if your state has laws that may help.
The NCI sponsors clinical trials around the country. There is no charge for medical care at NCI-sponsored clinical trials at the NIH Clinical Center in Bethesda, Maryland but patients are responsible for travel costs for their initial screening visit. Usually, once a patient is enrolled in a trial there, the NCI covers transportation costs for all later visits for patients who do not live locally and these patients usually receive a small daily amount for food and lodging expenses if they are being treated as outpatients. You can search their site for more information.
Note: different websites have different information, so look everywhere and call to find out as much as you can about what's available.
Who Sponsors Clinical Trials? Who Conducts Them?
Of the thousands of cancer clinical trials going on at any one time, the US National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), sponsors (pays for the costs of) a good portion of them. These studies are often run by NCI-sponsored cancer cooperative groups, which are networks of doctors and institutions across the country who specialize in a particular aspect of cancer.
There are currently 10 major cooperative groups conducting studies:
The other main sponsors of clinical trials are pharmaceutical and biotechnology companies, which must show that their medicines are safe and effective before they can be marketed. Other groups, such as some nonprofit organizations, also sponsor clinical trials.
- American College of Radiology Imaging Network (ACRIN)
- American College of Surgeons Oncology Group (ACOSOG)
- Cancer and Leukemia Group B (CALGB)
- Children's Oncology Group (COG)
- Eastern Cooperative Oncology Group (ECOG)
- Gynecologic Oncology Group (GOG)
- National Surgical Adjuvant Breast and Bowel Project (NSABP)
- North Central Cancer Treatment Group (NCCTG)
- Radiation Therapy Oncology Group (RTOG)
- Southwest Oncology Group (SWOG)
Researchers conduct clinical trials in many different settings. Major cancer centers are the most common; because they usually have the most advanced facilities and highly trained staffs, they can conduct all phases of clinical trials. But they are not the only places where these studies take place.
Community hospitals across the country also participate in clinical trials, although these are usually phase II or III studies. Many of these hospitals are part of the NCI’s Community Clinical Oncology Program (CCOP). CCOP members conduct the same clinical trials across the country. Community hospitals may conduct other, privately sponsored, studies as well.
Doctors in private practice can also be involved in clinical trials, either as members of cooperative groups or by being actively involved in private research. But many doctors decide not to conduct clinical research, for a variety of reasons.
Location and Contact Information
|United States, Alaska
||Alaska Regional Hospital Cancer Center, Anchorage, Alaska, 99508, United States; Recruiting
Saul E. Rivkin, MD 206-386-2929
|United States, Arizona
||Arizona Cancer Center at University of Arizona Health Sciences Center, Tucson, Arizona, 85724-5024, United States; Recruiting
Clinical Trials Office - Arizona Cancer Center 520-626-9008
|United States, California
||Providence Saint Joseph Medical Center - Burbank, Burbank, California, 91505, United States; Recruiting
Clinical Trials Office - Providence Saint Joseph Medical Cente 818-847-3220
|University of California Davis Cancer Center, Sacramento, California, 95817, United States; Recruiting
Clinical Trials Office - University of California Davis Cancer 916-734-3089
|USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, 90089-9181, United States; Recruiting
Clinical Trials Office - USC/Norris Comprehensive Cancer Cente 323-865-0451
|United States, Georgia
||Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center, Savannah, Georgia, 31403-3089, United States; Recruiting
Clinical Trials Office - Curtis & Elizabeth Anderson Cancer In 912-350-8568
|Northeast Georgia Medical Center, Gainesville, Georgia, 30501, United States; Recruiting
Charles H. Nash, MD 770-535-3553
|United States, Illinois
||Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, 60153, United States; Recruiting
Clinical Trials Office - Cardinal Bernardin Cancer Center 708-226-4357
|Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, 62526, United States; Recruiting
James L. Wade, MD 217-876-6600
|Regional Cancer Center at Memorial Medical Center, Springfield, Illinois, 62781-0001, United States; Recruiting
Clinical Trials Office - Regional Cancer Center 217-788-4233
|United States, Indiana
||Reid Hospital & Health Care Services, Incorporated, Richmond, Indiana, 47374, United States; Recruiting
Howard M. Gross, MD 765-983-3000
|St. Francis Hospital and Health Centers - Beech Grove Campus, Beech Grove, Indiana, 46107, United States; Recruiting
Howard M. Gross, MD 317-787-3311
|United States, Iowa
||Genesis Regional Cancer Center at Genesis Medical Center, Davenport, Iowa, 52803, United States; Recruiting
George Kovach, MD 563-421-1960
|United States, Kansas
||Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center, Kansas City, Kansas, 66160-7357, United States; Recruiting
Clinical Trials Office - Kansas Masonic Cancer Research Instit 913-588-4709
|Tammy Walker Cancer Center at Salina Regional Health Center, Salina, Kansas, 67401, United States; Recruiting
William F. Cathcart-Rake, MD 785-827-7261
|United States, Massachusetts
||Cancer Research Center at Boston Medical Center, Boston, Massachusetts, 02118, United States; Recruiting
Ken S. Zaner, MD, PhD 617-638-5631
|Caritas St. Elizabeth's Medical Center, Boston, Massachusetts, 02135-2997, United States; Recruiting
Paul J. Hesketh, MD 617-789-2317
|United States, Michigan
||Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201-1379, United States; Recruiting
Clinical Trials Office - Barbara Ann Karmanos Cancer Institute 800-527-6266
|CCOP - Michigan Cancer Research Consortium, Ann Arbor, Michigan, 48106, United States; Recruiting
Philip J. Stella, MD 877-590-5995
|Foote Hospital, Jackson, Michigan, 49201, United States; Recruiting
Philip J. Stella, MD 517-788-4800
|Genesys Hurley Cancer Institute, Flint, Michigan, 48503, United States; Recruiting
Clinical Trials Office - Genesys Hurley Cancer Institute 810-762-8057
|Hurley Medical Center, Flint, Michigan, 48503, United States; Recruiting
Clinical Trials Office - Hurley Medical Center 810-762-8057
|Josephine Ford Cancer Center at Henry Ford Hospital, Detroit, Michigan, 48202, United States; Recruiting
Robert A. Chapman, MD 313-916-1850
|Oakwood Cancer Center at Oakwood Hospital and Medical Center, Dearborn, Michigan, 48123-2500, United States; Recruiting
Clinical Trials Office - Oakwood Cancer Center 313-593-8090
|Saint Joseph Mercy Cancer Center, Ann Arbor, Michigan, 48106-0995, United States; Recruiting
Philip J. Stella, MD 734-712-5658
|Seton Cancer Institute - Saginaw, Saginaw, Michigan, 48601, United States; Recruiting
Oncology Research Center 989-776-8411
|Sparrow Regional Cancer Center, Lansing, Michigan, 48909, United States; Recruiting
Philip J. Stella, MD 517-364-2780
|St. John Macomb Hospital, Warren, Michigan, 48093, United States; Recruiting
Philip J. Stella, MD 586-573-5757
|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109-0942, United States; Recruiting
Clinical Trials Office - University of Michigan Comprehensive 800-865-1125
|Van Elslander Cancer Center at St. John Hospital and Medical Center, Grosse Pointe Woods, Michigan, 48236, United States; Recruiting
Clincial Trials Office - Van Elslander Cancer Center 313-343-3166
|United States, Missouri
||CCOP - Cancer Research for the Ozarks, Springfield, Missouri, 65802, United States; Recruiting
John W. Goodwin, MD 417-889-8099
|CCOP - Kansas City, Kansas City, Missouri, 64131, United States; Recruiting
Rakesh Gaur, MD 816-823-0555
|Hulston Cancer Center at Cox Medical Center South, Springfield, Missouri, 65807, United States; Recruiting
John W. Goodwin, MD 417-889-8099
|Saint Louis University Cancer Center, Saint Louis, Missouri, 63110, United States; Recruiting
Clinical Trials Office - St. Louis University Cancer Center 314-977-4440
|St. John's Regional Health Center, Springfield, Missouri, 65804, United States; Recruiting
John W. Goodwin, MD 417-889-8099
|United States, Montana
||Great Falls, Montana, 59405, United States; Recruiting
Donald H. Berdeaux, MD, FACP 406-452-4322
|Big Sky Oncology, Great Falls, Montana, 59405, United States; Recruiting
Grant W. Harrer, MD, FACP, CCTI 406-455-2820
|Billings Clinic Cancer Center, Billings, Montana, 59107-5100, United States; Recruiting
Clinical Trials Office - Billings Clinic Cancer Center 800-996-2663 [email protected]
|Bozeman Deaconess Cancer Center, Bozeman, Montana, 59715, United States; Recruiting
Contact Person 406-585-5000
|CCOP - Montana Cancer Consortium, Billings, Montana, 59101, United States; Recruiting
Contact Person 406-259-2245
|Community Medical Center, Missoula, Montana, 59801, United States; Recruiting
Contact Person 406-728-4100
|Deaconess Billings Clinic - Downtown, Billings, Montana, 59107-7000, United States; Recruiting
Clinical Trials Office - Deaconess Billings Clinic - Downtown 800-996-2663 [email protected]
|Glacier Oncology, PLLC, Kalispell, Montana, 59901, United States; Recruiting
Contact Person 406-752-7600
|Great Falls Clinic, Great Falls, Montana, 59405, United States; Recruiting
Thomas A. Warr, MD 406-727-4584
|Guardian Oncology and Center for Wellness, Missoula, Montana, 59804, United States; Recruiting
Contact Person 406-721-1118
|Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, 59101, United States; Recruiting
Contact Person 406-238-6290
|Kalispell Medical Oncology, Kalispell, Montana, 59901, United States; Recruiting
Contact Person 406-752-8900
|Kalispell Regional Medical Center, Kalispell, Montana, 59901, United States; Recruiting
Contact Person 406-752-5111
|Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, 59807, United States; Recruiting
Clinical Trials Office - Montana Cancer Center 406-329-7029
|Montana Cancer Specialists at Montana Cancer Center, Missoula, Montana, 59807-7877, United States; Recruiting
Clinical Trials Office - Montana Cancer Specialists 406-238-6962
|Northern Rockies Radiation Oncology Center, Billings, Montana, 59101, United States; Recruiting
Contact Person 406-248-2212
|Sletten Regional Cancer Institute at Benefis Healthcare, Great Falls, Montana, 59405, United States; Recruiting
Grant W. Harrer, MD, FACP, CCTI 406-455-2820
|St. James Community Hospital, Butte, Montana, 59701, United States; Recruiting
Contact Person 406-782-8361
|St. Peter's Hospital, Helena, Montana, 59601, United States; Recruiting
Contact Person 406-442-2480
|St. Vincent Healthcare, Billings, Montana, 59101, United States; Recruiting
Contact Person 406-657-7000
|United States, New Mexico
||University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico, 87131-5636, United States; Recruiting
Clinical Trials Office - University of New Mexico Cancer Resea 505-272-6972
|United States, North Carolina
||Presbyterian Cancer Center at Presbyterian Hospital, Charlotte, North Carolina, 28233-3549, United States; Recruiting
Clinical Trials Office - Presbyterian Cancer Center 704-384-5369
|Rutherford Hospital, Rutherfordton, North Carolina, 28139, United States; Recruiting
James D. Bearden, MD 864-560-6812
|Wayne Memorial Hospital, Incorporated, Goldsboro, North Carolina, 27534, United States; Recruiting
Contact Person 919-736-1110
|United States, Ohio
||CCOP - Dayton, Dayton, Ohio, 45429, United States; Recruiting
Howard M. Gross, MD 937-395-8678
|Charles F. Kettering Memorial Hospital, Kettering, Ohio, 45429, United States; Recruiting
Clinical Trials Office - Charles F. Kettering Memorial Hospita 937-298-3399 ext. 55506
|Cleveland Clinic - Wooster, Wooster, Ohio, 44691, United States; Recruiting
Clinical Trials Office - Cleveland Clinic - Wooster 800-862-7798
|Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, 44195, United States; Recruiting
George T. Budd, MD 216-444-7923
|Community Oncology Group at Cleveland Clinic Cancer Center, Independence, Ohio, 44131, United States; Recruiting
George T. Budd, MD 216-447-9747
|David L. Rike Cancer Center at Miami Valley Hospital, Dayton, Ohio, 45409, United States; Recruiting
Clinical Trials Office - David L. Rike Cancer Center 937-208-2079
|Good Samaritan Hospital, Dayton, Ohio, 45406, United States; Recruiting
Howard M. Gross, MD 937-278-2612
|Grandview Hospital, Dayton, Ohio, 45405, United States; Recruiting
Howard M. Gross, MD 937-226-3200
|Middletown Regional Hospital, Middletown, Ohio, 45044, United States; Recruiting
Howard M. Gross, MD 513-424-2111
|Ruth G. McMillan Cancer Center at Greene Memorial Hospital, Xenia, Ohio, 45385, United States; Recruiting
Howard M. Gross, MD 937-352-2140
|Samaritan North Cancer Care Center, Dayton, Ohio, 45415, United States; Recruiting
Howard M. Gross, MD 937-279-5800
|UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, 45373-1300, United States; Recruiting
Clinical Trials Office - UVMC Cancer Care Center 937-440-4842
|Veterans Affairs Medical Center - Dayton, Dayton, Ohio, 45428, United States; Recruiting
Howard M. Gross, MD 937-268-6511
|United States, Oregon
||St. Charles Medical Center - Bend, Bend, Oregon, 97701, United States; Recruiting
Robert Boone, MD 541-317-4298
|United States, South Carolina
||AnMed Cancer Center, Anderson, South Carolina, 29621, United States; Recruiting
Clinical Trials Office - Rose Ramer Cancer Clinic 864-261-2099
|Bon Secours St. Francis Health System, Greenville, South Carolina, 29601, United States; Recruiting
Clinical Trails Office - Bon Secours St. Francis Health System 864-255-1713
|CCOP - Greenville, Greenville, South Carolina, 29615, United States; Recruiting
Jeffrey K. Giguere, MD, FACP 864-241-6251
|CCOP - Upstate Carolina, Spartanburg, South Carolina, 29303, United States; Recruiting
Clinical Trials Office - CCOP - Upstate Carolina 800-486-5941
|Gibbs Regional Cancer Center at Spartanburg Regional Medical Center, Spartanburg, South Carolina, 29303, United States; Recruiting
Clinical Trials Office - Gibbs Regional Cancer Center 800-486-5941
|Roper St. Francis Cancer Center at Roper Hospital, Charleston, South Carolina, 29401, United States; Recruiting
James M. Orcutt, MD 843-577-2276
|United States, Tennessee
||Christine LaGuardia Phillips Cancer Center at Wellmont Holston Valley Medical Center, Kingsport, Tennessee, 37662, United States; Recruiting
Clinical Trials Office - Christine LaGuardia Phillips Cancer C 423-224-5593
|United States, Texas
||M.D. Anderson Cancer Center at University of Texas, Houston, Texas, 77030-4009, United States; Recruiting
Clinical Trials Office - M.D. Anderson Cancer Center 713-792-3245
|United States, Utah
||American Fork Hospital, American Fork, Utah, 84003, United States; Recruiting
W. G. Harker, MD 801-269-0231
|Cottonwood Hospital Medical Center, Murray, Utah, 84107, United States; Recruiting
W. G. Harker, MD 801-269-0231
|Dixie Regional Medical Center - East Campus, Saint George, Utah, 84770, United States; Recruiting
Clinical Trials Office - Dixie Regional Medical Center 435-688-4167
|Latter Day Saints Hospital, Salt Lake City, Utah, 84103, United States; Recruiting
W. G. Harker, MD 801-269-0231
|Logan Regional Hospital, Logan, Utah, 84321, United States; Recruiting
W. G. Harker, MD 801-269-0231
|McKay-Dee Hospital Center, Ogden, Utah, 84403, United States; Recruiting
Clinical Trials Office - McKay-Dee Hospital Center 801-387-7426
|Utah Cancer Specialists at UCS Cancer Center, Salt Lake City, Utah, 84106, United States; Recruiting
W. G. Harker, MD 801-269-0231
|Utah Valley Regional Medical Center - Provo, Provo, Utah, 84604, United States; Recruiting
Clinical Trials Office - Utah Valley Regional Medical Center - 801-357-7965
|United States, Virginia
||Danville Regional Medical Center, Danville, Virginia, 24541, United States; Recruiting
Clinical Trials Office - Danville Regional Medical Center 434-799-3753
|Southwest Virginia Regional Cancer Center, Norton, Virginia, 24273, United States; Recruiting
Malcolm R. Mathews, MD 423-224-3150
|United States, Washington
||Columbia Basin Hematology, Kennewick, Washington, 99336, United States; Recruiting
Thomas A. Rado, MD, PhD 509-783-0144
|United States, Wyoming
||Welch Cancer Center at Sheridan Memorial Hospital, Sheridan, Wyoming, 82801, United States; Recruiting
Contact Person 307-674-6022